Axsome Therapeutics Stock Jumped: April Rally and What It Means for Investors
Axsome Therapeutics rode a powerful April rally driven by Auvelity performance and pipeline momentum. This article br...
Compare tax costs between dividend ETFs and mutual funds to determine which option generally incurs higher or lower taxes in real scenarios.
28,480 articlesAxsome Therapeutics rode a powerful April rally driven by Auvelity performance and pipeline momentum. This article br...
Digital Turbine APPS reported Q1 2026 results that highlighted continued monetization momentum and strategic partners...
With earnings on the horizon and a bold pivot to AI infrastructure, investors face a tough call. This guide breaks do...
As the maha movement coming school expands into cafeteria menus, districts face higher costs from stricter nutrition ...
The 2026 housing market predictions headline a continued stretch of seller pain and tighter credit. This guide breaks...
Lucid has dazzled with tech and range, but deep cash burn and production headwinds spark serious questions. Here’s a ...
A high-profile insider sale at UroGen Pharma raises questions about market signals and biotech risk. This article unp...
Three practical lessons from SpaceX’s IPO can guide investors as Anthropic and OpenAI approach the market. Learn how ...
Meme coins can surprise with sudden moves, and Pepe is no exception. This article unpacks the drivers behind a sharp ...
MercadoLibre's fourth-quarter results showed strong revenue growth, but a notable drop in profitability. This article...
A single-day surge can feel like a blockbuster, but smart readers want the real story. This guide breaks down why IMA...
A congressional hearing places federal fraud losses close to $1 trillion annually, far surpassing GAO estimates, as e...